CD8A and neoplasm: Furthermore, a population of IL-15-induced human circulating NKp30+FcεR1γ+ CD8+ T cells was described to exhibit high NK-like anti-tumor activity in vitro and in a preclinical xenograft mouse model in vivo (62).